Inventor · disambiguated record
Natalie Dales
Also filed as: DALES NATALIE · DALES NATALIE A · DALES NATALIE ALYSIA
28 granted patents·15 pending applications·221 citations·filing 1998–2024
96Inventor score
Top patents by PatentIndex Score
43 records- 0194US10195196B21,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditionsNOVARTIS AG·Filed 2016·Granted Feb 5, 2019·15 cites·9 claims
- 0294US8729263B21,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditionsCHEUNG ATWOOD KIM·Filed 2013·Granted May 20, 2014·45 cites·5 claims
- 0391US9545404B21,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditionsNOVARTIS AG·Filed 2014·Granted Jan 17, 2017·16 cites·10 claims
- 0491US7935694B2Lactam compounds useful as protein kinase inhibitorsMILLENNIUM PHARM INC·Filed 2008·Granted May 3, 2011·8 cites·22 claims
- 0590US7459448B2Lactam compounds useful as protein kinase inhibitorsMILLENNIUM PHARM INC·Filed 2005·Granted Dec 2, 2008·8 cites·22 claims
- 0688US11566022B23-(5-methoxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereofNOVARTIS AG·Filed 2020·Granted Jan 31, 2023·2 cites·20 claims
- 0787US10758533B21,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditionsNOVARTIS AG·Filed 2019·Granted Sep 1, 2020·2 cites·8 claims
- 0886US8314138B2Pyrazole derivative as SCD1 inhibitors for the treatment of diabetesDALES NATALIE·Filed 2007·Granted Nov 20, 2012·10 cites·2 claims
- 0986US8258160B2SCD1 inhibitors triazole and tetrazole compoundsDALES NATALIE·Filed 2007·Granted Sep 4, 2012·11 cites·17 claims
- 1086US6632830B1ACE-2 inhibiting compounds and methods of use thereofMILLENNIUM PHARM INC·Filed 2000·Granted Oct 14, 2003·30 cites·145 claims
- 1185US8049016B2Thiazole derivatives which inhibit stearoyl-CoA desaturase enzymesNOVARTIS AG·Filed 2009·Granted Nov 1, 2011·7 cites·19 claims
- 1283US12252482B2Pyrazolopyridine derivatives and uses thereofNOVARTIS AG·Filed 2024·Granted Mar 18, 2025·0 cites·22 claims
- 1383US9040712B2Thiadiazole analogs thereof and methods for treating SMN-deficiency-related-conditionsAXFORD JAKE·Filed 2014·Granted May 26, 2015·13 cites·16 claims
- 1483US8063084B2Heterocyclic compounds suitable for the treatment of diseases related to elevated lipid levelsDALES NATALIE·Filed 2007·Granted Nov 22, 2011·6 cites·14 claims
- 1582US2025282762A1Pyrazolopyridine derivatives and uses thereofNOVARTIS AG·Filed 2024·Application pending·0 cites
- 1679US12172984B2Pyrazolopyridine derivatives and uses thereofNOVARTIS AG·Filed 2023·Granted Dec 24, 2024·0 cites·30 claims
- 1778US8501746B2Organic compoundsDALES NATALIE·Filed 2007·Granted Aug 6, 2013·3 cites·16 claims
- 1878US7045532B2ACE-2 modulating compounds and methods of use thereofMILLENNIUM PHARM INC·Filed 2001·Granted May 16, 2006·11 cites·40 claims
- 1977US2022387428A11,4-disubstituted pyridazine analogs there of and methods for treating smn-deficiency-related conditionsNOVARTIS AG·Filed 2021·Application pending·0 cites
- 2077US2024009189A11,4-disubstituted pyridazine quinolne analogs there of and methods for treating smn-deficiency-related conditionsNOVARTIS AG·Filed 2023·Application pending·0 cites
- 2174US6433199B1Quinone derivativesSHIONOGI BIORES CORP·Filed 1999·Granted Aug 13, 2002·20 cites·8 claims
- 2273US11787785B2Pyrazolopyridine derivatives and uses thereofNOVARTIS AG·Filed 2022·Granted Oct 17, 2023·0 cites·15 claims
- 2372US11229648B21,4-disubstituted pyridazine analogs thereof and methods for treating SMN-deficiency-related conditionsNOVARTIS AG·Filed 2020·Granted Jan 25, 2022·0 cites·24 claims
- 2466US11672799B21,4-disubstituted pyridazine quinolne analogs there of and methods for treating SMN-deficiency-related conditionsNOVARTIS AG·Filed 2019·Granted Jun 13, 2023·0 cites·9 claims
- 2565US5969133ABioreductive cytotoxic agentsSHIONGI BIORESEARCH CORP·Filed 1998·Granted Oct 19, 1999·14 cites·21 claims
- 2664US9187426B2Organic compoundsDALES NATALIE·Filed 2009·Granted Nov 17, 2015·0 cites·2 claims
- 2759US2012178739A1Lactam compounds useful as protein kinase inhibitorsBLACKBURN CHRISTOPHER·Filed 2012·Application pending·0 cites
- 2857US2016184305A11,4-disubstituted pyridazine quinolne analogs there of and methods for treating smn-deficiency-related conditionsCHEUNG ATWOOD·Filed 2014·Application pending·0 cites
- 2956US2025276964A1Benzisoxazole Derivatives and Uses thereofNOVARTIS AG·Filed 2022·Application pending·0 cites
- 3054US8293768B2Organic compoundsDALES NATALIE·Filed 2011·Granted Oct 23, 2012·0 cites·2 claims
- 3154US2023279394A1Compositions and methods for the treatment of hemoglobinopathiesNOVARTIS AG·Filed 2020·Application pending·0 cites
- 3253US2005245563A1Chk-1 inhibitorsMILLENNIUM PHARM INC·Filed 2004·Application pending·0 cites
- 3352US2011039820A1Lactam compounds useful as protein kinase inhibitorsMILLENNIUM PHARM INC·Filed 2010·Application pending·0 cites
- 3451US2014024583A1Organic compoundsNOVARTIS AG·Filed 2013·Application pending·0 cites
- 3548US8236835B2Heterocyclic inhibitors of stearoyl-CoA desaturaseDALES NATALIE·Filed 2007·Granted Aug 7, 2012·0 cites·9 claims
- 3646US8318949B2Organic compoundsCHOWDHURY SULTAN·Filed 2011·Granted Nov 27, 2012·0 cites·11 claims
- 3744US10654828B2Indole derivatives and uses thereofNOVARTIS AG·Filed 2018·Granted May 19, 2020·0 cites·17 claims
- 3843US10633350B2Diphenyl derivatives and uses thereofNOVARTIS AG·Filed 2018·Granted Apr 28, 2020·0 cites·16 claims
- 3943US2006035920A1Chk-1 inhibitorsMILLENNIUM PHARM INC·Filed 2005·Application pending·0 cites
- 4042US2016289191A1Organic compoundsDALES NATALIE·Filed 2015·Application pending·0 cites
- 4137US2013011361A1Pyrazole derivatives which modulate stearoyl-coa desaturaseXENON PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 4236US2015218175A1Thiadiazole analogs thereof and methods for treating smn-deficiency-related-conditionsAXFORD JAKE·Filed 2015·Application pending·0 cites
- 4335US2012010135A1Spiro derivatives for the modulation of stearoyl-coa desaturaseDALES NATALIE·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →